Literature DB >> 16174647

Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis.

T Cobo Ibáñez, M Yehia Tayel, A Balsa Criado, A Hernández Sanz, E Martín Mola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16174647     DOI： 10.1093/rheumatology/kei130

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  [Leflunomide in combination with TNF-blockers for Methotrexate intolerance].

Authors:  K Krüger; B Manger
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

2.  Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.

Authors:  Renato De Stefano; Elena Frati; Fernando Nargi; Caterina Baldi; Luana Menza; Mohammed Hammoud; Mauro Galeazzi
Journal:  Clin Rheumatol       Date:  2010-01-16       Impact factor: 2.980

Review 3.  Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.

Authors:  Peter Bb Jones; Douglas Hn White
Journal:  Open Access Rheumatol       Date:  2010-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.